Cambridge Investment Research Advisors
RNLX

Cambridge Investment Research Advisors’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,500
Closed -$3K – 3642
2024
Q3 		$3K Buy
+14,500
New +$4.63K ﹤0.01% 3402

Other funds holding RNLX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
IIC
Ironwood Investment Counsel Scottsdale, Arizona $762M AUM 23.02% 1-Year Est. Return

Cambridge Investment Research Advisors's RNLX Position: Q4 2024 in Review

Cambridge Investment Research Advisors sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 14,500 shares — an estimated $3K sold.

Cambridge Investment Research Advisors first reported a position in RNLX in Q3 2024 and held it in 1 quarter. The position peaked at $3K in Q3 2024. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • Cambridge Investment Research Advisors reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 14,500 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $3K.
  • Cambridge Investment Research Advisors first reported a position in Renalytix plc American Depositary Shares in Q3 2024 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Renalytix plc American Depositary Shares position peaked at $3K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.